• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Role of amyloid β protein receptors in mediating synaptic plasticity.淀粉样β蛋白受体在介导突触可塑性中的作用。
Biomed Rep. 2017 Apr;6(4):379-386. doi: 10.3892/br.2017.863. Epub 2017 Feb 21.
2
A mechanistic hypothesis for the impairment of synaptic plasticity by soluble Aβ oligomers from Alzheimer's brain.阿尔茨海默病脑源性可溶性 Aβ 寡聚体损伤突触可塑性的机制假说。
J Neurochem. 2020 Sep;154(6):583-597. doi: 10.1111/jnc.15007. Epub 2020 Apr 5.
3
Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.人脑源性β淀粉样蛋白寡聚体以一种需要淀粉样前体蛋白(APP)的方式与突触结合并破坏突触活动。
J Neurosci. 2017 Dec 6;37(49):11947-11966. doi: 10.1523/JNEUROSCI.2009-17.2017. Epub 2017 Nov 3.
4
Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies.β-淀粉样蛋白对突触可塑性的破坏:潜在的阿尔茨海默病改善疗法的调节作用
Biochem Soc Trans. 2005 Aug;33(Pt 4):563-7. doi: 10.1042/BST0330563.
5
Systematic characterization of a non-transgenic Aβ amyloidosis model: synaptic plasticity and memory deficits in female and male mice.系统表征非转基因 Aβ 淀粉样变性模型:雌性和雄性小鼠的突触可塑性和记忆缺陷。
Biol Sex Differ. 2023 Sep 16;14(1):59. doi: 10.1186/s13293-023-00545-4.
6
Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.突触活动在阿尔茨海默病中对β-淀粉样蛋白水平调节的作用
Neurobiol Aging. 2014 Jun;35(6):1217-32. doi: 10.1016/j.neurobiolaging.2013.11.021. Epub 2013 Nov 28.
7
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.非纤维状β淀粉样蛋白通过靶向突触后AMPA受体减弱新皮层2/3层兴奋性突触处的尖峰时间依赖性突触增强。
Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x.
8
Amyloid Beta Oligomers Target to Extracellular and Intracellular Neuronal Synaptic Proteins in Alzheimer's Disease.淀粉样β寡聚体靶向阿尔茨海默病中的细胞外和细胞内神经元突触蛋白。
Front Neurol. 2019 Nov 1;10:1140. doi: 10.3389/fneur.2019.01140. eCollection 2019.
9
Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.双(丙基)-认知素通过激活PI3-K途径预防β-淀粉样蛋白诱导的记忆缺陷以及突触形成和可塑性损伤。
Mol Neurobiol. 2016 Aug;53(6):3832-3841. doi: 10.1007/s12035-015-9317-9. Epub 2015 Jul 10.
10
Large Soluble Oligomers of Amyloid β-Protein from Alzheimer Brain Are Far Less Neuroactive Than the Smaller Oligomers to Which They Dissociate.来自阿尔茨海默病大脑的淀粉样β蛋白的大可溶性寡聚体的神经活性远低于它们解离形成的较小寡聚体。
J Neurosci. 2017 Jan 4;37(1):152-163. doi: 10.1523/JNEUROSCI.1698-16.2016.

引用本文的文献

1
Endothelial delivery of simvastatin by LRP1-targeted nanoparticles ameliorates pathogenesis of alzheimer's disease in a mouse model.通过靶向低密度脂蛋白受体相关蛋白1(LRP1)的纳米颗粒进行辛伐他汀的内皮递送可改善阿尔茨海默病小鼠模型的发病机制。
Alzheimers Res Ther. 2025 Aug 20;17(1):193. doi: 10.1186/s13195-025-01840-5.
2
DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss.DL0410 通过促进突触传递和减少神经元丢失改善 APP/PS1 转基因小鼠的认知缺陷。
Acta Pharmacol Sin. 2020 May;41(5):599-611. doi: 10.1038/s41401-019-0312-y. Epub 2019 Nov 4.
3
Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions.睡茄内酯A抑制表达淀粉样前体蛋白细胞中的β淀粉样蛋白:对与塔他蛋白和可卡因相关的神经功能障碍的研究
Front Aging Neurosci. 2018 Sep 27;10:291. doi: 10.3389/fnagi.2018.00291. eCollection 2018.
4
Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?早期对神经元损伤的代偿反应:阿尔茨海默病治疗的新机会窗口?
CNS Neurosci Ther. 2019 Jan;25(1):5-13. doi: 10.1111/cns.13050. Epub 2018 Aug 12.

本文引用的文献

1
The amyloid hypothesis of Alzheimer's disease at 25 years.阿尔茨海默病淀粉样蛋白假说25年回顾
EMBO Mol Med. 2016 Jun 1;8(6):595-608. doi: 10.15252/emmm.201606210. Print 2016 Jun.
2
Alzheimer's disease-like APP processing in wild-type mice identifies synaptic defects as initial steps of disease progression.野生型小鼠中类似阿尔茨海默病的淀粉样前体蛋白加工过程将突触缺陷确定为疾病进展的初始步骤。
Mol Neurodegener. 2016 Jan 12;11:5. doi: 10.1186/s13024-016-0070-y.
3
Amyloid-β Receptors: The Good, the Bad, and the Prion Protein.淀粉样β受体:有益的、有害的与朊病毒蛋白
J Biol Chem. 2016 Feb 12;291(7):3174-83. doi: 10.1074/jbc.R115.702704. Epub 2015 Dec 30.
4
Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit.缺乏α7烟碱型受体亚基的小鼠视觉皮层中突触可塑性受损。
Neuroscience. 2015 May 21;294:166-71. doi: 10.1016/j.neuroscience.2015.03.022. Epub 2015 Mar 19.
5
Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease.在阿尔茨海默病PS2APP小鼠模型早期病理过程中,GluN2B N-甲基-D-天冬氨酸受体功能及突触可塑性的改变
Neurobiol Dis. 2015 Feb;74:254-62. doi: 10.1016/j.nbd.2014.11.017. Epub 2014 Dec 4.
6
The Binding Receptors of Aβ: an Alternative Therapeutic Target for Alzheimer's Disease.β淀粉样蛋白的结合受体:阿尔茨海默病的另一种治疗靶点。
Mol Neurobiol. 2016 Jan;53(1):455-471. doi: 10.1007/s12035-014-8994-0. Epub 2014 Dec 4.
7
mGlu5 receptors and cellular prion protein mediate amyloid-β-facilitated synaptic long-term depression in vivo.代谢型谷氨酸受体5(mGlu5)和细胞朊蛋白在体内介导β-淀粉样蛋白促进的突触性长时程抑制。
Nat Commun. 2014 Mar 4;5:3374. doi: 10.1038/ncomms4374.
8
Role of synaptic activity in the regulation of amyloid beta levels in Alzheimer's disease.突触活动在阿尔茨海默病中对β-淀粉样蛋白水平调节的作用
Neurobiol Aging. 2014 Jun;35(6):1217-32. doi: 10.1016/j.neurobiolaging.2013.11.021. Epub 2013 Nov 28.
9
Exosomes neutralize synaptic-plasticity-disrupting activity of Aβ assemblies in vivo.外泌体可中和体内 Aβ 聚集物破坏突触可塑性的活性。
Mol Brain. 2013 Nov 13;6:47. doi: 10.1186/1756-6606-6-47.
10
Human LilrB2 is a β-amyloid receptor and its murine homolog PirB regulates synaptic plasticity in an Alzheimer's model.人 LilrB2 是 β-淀粉样蛋白受体,其鼠同源物 PirB 在阿尔茨海默病模型中调节突触可塑性。
Science. 2013 Sep 20;341(6152):1399-404. doi: 10.1126/science.1242077.

淀粉样β蛋白受体在介导突触可塑性中的作用。

Role of amyloid β protein receptors in mediating synaptic plasticity.

作者信息

Li Yu, Sun Zhongqing, Cao Qiaoyu, Chen Meiwan, Luo Huanmin, Lin Xi, Xiao Fei

机构信息

Department of Pharmacology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, P.R. China.

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau 999078, P.R. China.

出版信息

Biomed Rep. 2017 Apr;6(4):379-386. doi: 10.3892/br.2017.863. Epub 2017 Feb 21.

DOI:10.3892/br.2017.863
PMID:28413635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5374942/
Abstract

There are few diseases in modern biomedicine that have garnered as much scientific interest and public concern as Alzheimer's disease (AD). The amyloid hypothesis has become the dominant model of AD pathogenesis; however, the details of the hypothesis are changing over time. Recently, given the increasing recognition, subtle effects of amyloid β protein (Aβ) on synaptic efficacy may be critical to AD progression. Synaptic plasticity is the important neurochemical foundation of learning and memory. Recent studies have identified that soluble Aβ oligomers combine with certain receptors to impair synaptic plasticity in AD, which advanced the amyloid hypothesis. The aim of the present review was to summarize the role of Aβ-relevant receptors in regulating synaptic plasticity and their downstream signaling cascades, which may provide novel insights into the understanding of the pathogenesis of AD and the development of therapeutic strategies to slow down the progression of AD-associated memory decline in the early stages.

摘要

在现代生物医学中,很少有疾病能像阿尔茨海默病(AD)那样引起如此多的科学关注和公众关切。淀粉样蛋白假说已成为AD发病机制的主导模型;然而,该假说的细节也在随时间不断变化。最近,鉴于人们越来越认识到,淀粉样β蛋白(Aβ)对突触效能的微妙影响可能对AD进展至关重要。突触可塑性是学习和记忆重要的神经化学基础。最近的研究已经确定,可溶性Aβ寡聚体与某些受体结合,损害AD中的突触可塑性,这推进了淀粉样蛋白假说。本综述的目的是总结与Aβ相关的受体在调节突触可塑性及其下游信号级联反应中的作用,这可能为理解AD的发病机制以及制定治疗策略以减缓AD相关记忆衰退早期进展提供新的见解。